Paul T. Parker
- Firmwide Chair, Medical Device Industry Group
- Seattle
- Palo Alto
Paul has over 20 years of experience and focuses his practice on emerging medical device companies, with particular experience in cardiovascular, renal neuromodulation, neurostimulation, spinal devices, and aesthetic treatments.
Paul Parker, firmwide chair of Perkins Coie's Medical Device industry sector, has represented investors and emerging companies from incubation through acquisition/IPO. In the past two years, he was involved in raising over $100 million in venture funding for emerging medical device companies and has been involved in over $1 billion in acquisitions/IPOs since 2010. Paul also has extensive experience in portfolio development and patent strategies, freedom to operate analyses and other intellectual property due diligence, patent licensing, and technology transfer.
Education & Credentials
Education
- University of Minnesota Law School, J.D., magna cum laude, Order of the Coif, 1993
- Washington State University, B.S., Mechanical Engineering, cum laude, 1984
Bar and Court Admissions
-
Washington
-
U.S. Patent and Trademark Office
- U.S. District Court for the District of Minnesota
- U.S. District Court for the Western District of Washington
Related Employment
- Seed & Berry, Seattle, WA, Associate, 1995-1999
- Fredrikson & Byron, P.A., Minneapolis, MN, Associate, 1993-1995
Professional Recognition
Named IAM Global Leader, 2020-2024
Listed in LMG Life Sciences 2019 as an "Intellectual Property Star"
Highly recommended in Intellectual Asset Management Patent 1000, 2012-2024
Recognized as an IP Star by Managing IP, 2013-2014, 2016-2024
Listed in Super Lawyers Magazine, “Washington’s Super Lawyers," 2001-2018
Listed in Seattle Magazine, “Seattle’s Best Lawyers," 2003
Ranked by Chambers USA as “America’s Leading Lawyer" for Intellectual Property, 2007-2024
Listed in Best Lawyers in America: Litigation - Intellectual Property; Litigation - Patent; Patent Law, 2009-2025
Insights
News
Professional Experience
Patent
Micron Technology Inc.
Patent portfolio planning, development and counseling, including patent preparation and prosecution in the fields of packaging, chemical-mechanical polishing, photolithography, image sensor design and fabrication, vapor deposition (atomic layer deposition, chemical vapor deposition and physical vapor deposition), and other wafer processing technologies.
Medtronic
Patent preparation, prosecution, counseling, strategic patent due diligence and opinions for the world's largest standalone medical device company in fields of renal denervation, heart valves and neurovascular devices.
FUJIFILM Holdings America Corporation
Patent preparation, prosecution, and counseling for Japanese multinational photography and imaging company in portable diagnostic ultrasound devices.
Ardian Inc.
Patent preparation, prosecution, and counseling for early stage medical device company developing a catheter-based treatment for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, metabolic syndrome and heart failure. Served as Ardian's IP counsel for several financing rounds, and Medtronic’s $800 million acquisition of Ardian in 2011.
Nevro
Patent preparation, prosecution, freedom to operate and counseling for spinal stimulation. Served as Nevro’s IP counsel for several financing rounds in 2012 and 2013 raising over $70 million.
Twelve
Patent preparation, prosecution, and strategic counseling for heart valve company. Served as IP counsel for several financing rounds, and Medtronic’s $458 million acquisition of Twelve in 2015.
Zeltiq Aesthetics
Patent preparation, prosecution and strategic counseling for aesthetic devices. Served as IP counsel for IPO in 2011.
Medina Medical
Patent preparation, prosecution, and strategic counseling for neurovascular company. Served as IP counsel for Medtronic’s $225 million acquisition of Medina in 2015.
Pulsar Vascular Inc.
Patent preparation, prosecution, and strategic counseling for a company with technology for the neurovascular treatment of complex aneurysms in its acquisition by DePuy Synthes Products, Inc., an affiliate of Codman Neuro, a global market leader in neurovascular and neurosurgery in 2016.
Altura Medical
Patent preparation, prosecution, and strategic counseling for endovascular aneurysm repair device company in its acquisition by Lombard Medical for $50.5 million in 2015.
Asthmatx
Patent preparation, prosecution and strategic counseling for RF-based asthma treatment. Served as IP counsel for over $200 million acquisition by Boston Scientific in 2010.
Frazier Company and Frazier Healthcare Ventures IV
Investor IP counsel for venture capital investments in early stage medical device companies in ultrasound, cardiac, guidance, and other technologies.
Accent Optical Inc.
Patent preparation and prosecution directed towards scatterometry and photoluminescence for diagnosing the status of semiconductor wafers during prosecution at submicron levels.
Calypso Medical Technologies, Inc.
Patent preparation and prosecution in wireless implantable transducers for guiding surgery, radiation, and other treatments. Company IP counsel through several rounds of financing in 2010.
Northstar Neuroscience Inc.
Patent preparation and prosecution for cortical neurostimulation to treat stroke, movement disorders, and other conditions. Company counsel through several rounds of financing and an IPO.
SemiTool, Inc.
Patent preparation and prosecution for electroplating, electroless plating, robotic equipment for processing semiconductor workpieces. Extensive experience in electroless and electrolytic processes for plating copper onto semiconductor workpieces.